MediPharm (09885.HK) announced its interim results for the period ending in June this year, with revenue of 8.814 billion Chinese yuan (same below), up 10.6% year-on-year. Turned from loss to profit, earning 21.82 million yuan, compared to a loss of 3.169 billion yuan in the same period last year; earnings per share are 0.03 yuan. No dividend will be distributed.

According to the non-international financial reporting standards, the adjusted net profit for the first half of the year increased by 30.3% year-on-year to 91.411 million yuan.